This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_THYROICD2_ENDOCRINE_EXALLC for full statistics.
Carcinoma in situ, thyroid and other endocrine glands
CD2_INSITU_THYROICD2_ENDOCRINE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
11 |
4. Check minimum number of eventsNone |
11 |
5. Include endpointsNone |
11 |
6. Filter based on genotype QC (FinnGen only) |
11 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D09
- Name in latin
- Carcinoma in situ glandulae thyreoideae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ, thyroid and other endocrine glands
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ, thyroid and other endocrine glands
- Carcinoma in situ of other and unspecified sites
- Carcinoma in situ of other and unspecified sites
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 11 | 9 | - |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | - |
| Median age at first event (years) | 46.66 | 44.82 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018418) pH of Serum or Plasma
6
25
4.02
1.50
4.3
5.2
—
7.4
—
0
5
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
11
77
+∞
1.47
8.5
4.1
pmol/l
17.9
15.2
3.92
11
69
(42870588) Differential panel, method unspecified - Blood
6
29
3.31
1.12
3.5
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
0
25
0.00
0.93
0.0
1.8
—
633.0
—
0
19
(3026493) Urate [Moles/volume] in Serum or Plasma
0
27
0.00
0.92
0.0
2.4
—
14990.5
—
0
22
(3029937) Albumin [Presence] in Urine by Test strip
0
27
0.00
0.92
0.0
5.7
—
0.0
—
0
10
(3013826) Glucose [Moles/volume] in Serum or Plasma
5
65
0.58
0.28
4.8
3.6
mmol/l
5.9
7.0
—
5
60
(3022145) Colonoscopy Study observation
0
10
0.00
0.22
0.0
1.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
10
0.00
0.22
0.0
2.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
11
97
+∞
0.22
9.5
4.8
mu/l
0.7
1.9
4.88
11
83
(3044889) 12 lead EKG panel
6
66
0.80
0.12
2.7
2.6
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.6
—
1.2
—
0
5
(3038515) Glucose [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.6
—
6.0
—
0
5
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
0
5
0.00
0.00
0.0
4.6
—
0.7
—
0
5
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
26.1
—
0
5
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
5
0.00
0.00
0.0
4.6
—
0.7
—
0
5
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
5
0.00
0.00
0.0
4.8
—
49.7
—
0
5
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
0.3
—
0
5
(3023323) Follitropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
29.4
—
0
5
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
11
101
+∞
0.00
16.5
19.8
umol/l
67.8
69.0
0.14
11
101
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5
49
1.04
0.00
4.2
5.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
5
0.00
0.00
0.0
8.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
1.6
—
0
6
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
0
6
0.00
0.00
0.0
3.0
—
1.1
—
0
6
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
0
6
0.00
0.00
0.0
3.0
—
0.5
—
0
6
(3036481) Cortisol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
541.2
—
0
6
(3027273) Bicarbonate [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
3.5
—
23.3
—
0
6
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
6.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5
55
0.83
0.00
1.4
2.1
nmol/l
59.0
80.7
—
5
48
(3019832) Treponema pallidum Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
0
8
0.00
0.00
0.0
6.5
—
1.2
—
0
8
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
7
0.00
0.00
0.0
4.3
—
129.1
—
0
7
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_THYROICD2_ENDOCRINE – Carcinoma in situ, thyroid and other endocrine glands
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).